Curis Operating Margin from 2010 to 2025
| CRIS Stock | USD 3.43 0.16 4.89% |
Check Curis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Curis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 218 K, Interest Expense of 2.1 M or Selling General Administrative of 14.3 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 4.33. Curis financial statements analysis is a perfect complement when working with Curis Valuation or Volatility modules.
Curis | Operating Margin |
Latest Curis' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Curis Inc over the last few years. It is Curis' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Curis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (4.91) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Curis Operating Margin Regression Statistics
| Arithmetic Mean | (3.66) | |
| Geometric Mean | 2.86 | |
| Coefficient Of Variation | (59.21) | |
| Mean Deviation | 1.78 | |
| Median | (3.95) | |
| Standard Deviation | 2.16 | |
| Sample Variance | 4.68 | |
| Range | 7.2229 | |
| R-Value | (0.36) | |
| Mean Square Error | 4.38 | |
| R-Squared | 0.13 | |
| Significance | 0.18 | |
| Slope | (0.16) | |
| Total Sum of Squares | 70.26 |
Curis Operating Margin History
About Curis Financial Statements
Curis shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Curis investors may analyze each financial statement separately, they are all interrelated. The changes in Curis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Curis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts. Curis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 60 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Curis Stock Analysis
When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.